ALS Investment Fund

ALS Investment Fund is a venture capital firm based in Amsterdam, Netherlands, established in 2016. The fund focuses on investing in biotech companies that develop drugs and diagnostics for neurodegenerative diseases, with a particular emphasis on Amyotrophic Lateral Sclerosis (ALS). Initiated by Dutch ALS patients and advised by Life Sciences Partners, ALS Investment Fund provides funding and strategic support to advance research, development, and commercialization of innovative therapies. They invest globally, with a focus on Europe and the US, leveraging deep disease-specific knowledge and an extensive network in the field.